Plavix 75 mg is an oral film-coated tablet containing clopidogrel. It reduces platelet activation, helping prevent platelets from sticking together. European Union indications include prevention of further atherothrombotic events after certain heart attacks or ischaemic strokes, established peripheral arterial disease, and specified acute coronary syndromes. Some treatment pathways deliberately combine it with aspirin.<\/p>\n
This summary concerns the 75 mg tablet, not an instruction to start dual antiplatelet treatment or a loading regimen. Why treatment was prescribed, the timing of an acute event and a coronary stent can change the appropriate plan. Clopidogrel is an antiplatelet medicine; instructions for warfarin or a factor Xa anticoagulant cannot simply be substituted.<\/p>\n
Bleeding and bruising are important adverse effects, including nosebleeds, gastrointestinal bleeding and bleeding around a procedure. Diarrhoea, abdominal discomfort and indigestion are also reported. Uncontrolled bleeding, blood in vomit, black stools or new symptoms suggestive of a stroke require urgent assessment. Rare severe blood disorders are another reason to seek prompt advice for unexplained bruising accompanied by fever or neurological symptoms.<\/p>\n
Tell the treating team and dentist about clopidogrel before surgery or an invasive procedure. After a coronary stent, interrupting treatment without cardiology advice may be dangerous. The prescriber should balance bleeding risk against the risk of a new clot rather than leaving the patient to choose which medicine to stop.<\/p>\n
Clopidogrel needs activation partly through the CYP2C19 enzyme. Omeprazole and esomeprazole can reduce that activation; European labelling discourages their combination with clopidogrel. NHS Specialist Pharmacy Service guidance advises using a different proton pump inhibitor when acid protection is needed. Separating doses by a few hours is not a reliable substitute for checking the combination.<\/p>\n
NSAID painkillers, anticoagulants, other antiplatelets and some antidepressants can increase bleeding. Genetic differences and other medicines may also influence response, so the complete medicine list matters. EU information prefers avoiding clopidogrel in pregnancy as a precaution and advises against continuing breastfeeding during treatment. These decisions need professional assessment, not an unsupervised change based on this summary.<\/p>\n
Source check: